XOMA logo

XOMA (XOMA)

Profile

Full Name

XOMA Royalty Corporation

Ticker Symbol

XOMA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 6, 1986

Indexes

Not included

Website

http://www.xoma.com

Employees

13

Key Details

Price

$20.36(+3.35%)

Market cap

$243.89M(Small cap)

Last Dividend

$0.54

TTM Dividend yield

2.65%

Annual revenue

$10.22M(+114.80% YoY)

Annual EPS

-$1.65(+59.16% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$20.36
XOMA price is $20.36

30-Day Relative Volume

0.48
XOMA 30-day relative volume is 0.48

Price Performance

Price Today change

+3.35%
XOMA price is up +3.35% today

Price YTD change

-22.53%
XOMA price is down -22.53% since January 1st

Price 1-year change

-22.29%
XOMA price is down -22.29% year-on-year

Price 3-year change

-20.28%
XOMA price is down -20.28% over the past 3 years

Price Range

Price All-time high

$11587.50
XOMA price is currently -99.82% below its historical high of $11587.50

Price 3-year low

$13.48
XOMA price is currently +51.04% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$243.89M
XOMA market capitalization is $243.89 million

Market cap 3-year change

-16.31%
XOMA market capitalization is down -16.31% over the past 3 years

Market cap All-time high

$1.19B
XOMA market capitalization is currently -79.57% below its historical high of $1.19 billion

Market cap sector rank

60.56%
XOMA market capitalization is higher than 60.56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.94%
XOMA shares outstanding is up +2.94% year-on-year

Shares Outstanding 3-Year Change

+4.99%
XOMA shares outstanding is up +4.99% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.86
XOMA beta is 0.86

200-day SMA

$26.49
XOMA price is currently -23.14% below its 200-day simple moving average

50-day SMA

$22.50
XOMA price is currently -9.50% below its 50-day simple moving average

RSI

41.00
XOMA 14-day relative strength index is 41.00

Volume

0.48
XOMA 30-day relative volume is 0.48

ATR

$1.26
XOMA average true range is $1.26

10-day Historical Volatility

53.10%
XOMA 10-day historical volatility is 53.10%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.54
XOMA last dividend was $0.54 per share, with an ex-dividend date of January 3, 2025

Next Dividend

-
XOMA next dividend has not yet been announced

Dividend per share

Dividend per share

$0.54
XOMA annual dividend per share is $0.54

Dividend per share Sector Rank

22.09%
XOMA annual dividend per share is higher than 22.09% of companies in Healthcare sector

Dividend per share 1-Year Change

-
XOMA annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
XOMA annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

2.65%
XOMA annual dividend yield is 2.65%

Dividend yield Sector Rank

56.47%
XOMA annual dividend yield is higher than 56.47% of companies in Healthcare sector

Other

Payout ratio

-39.59%
XOMA annual payout ratio is -39.59%

Dividends paid

$5.47M
XOMA annual dividends paid is $5.47 million

Free cash flow

-$13.77M
XOMA annual free cash flow is -$13.77 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$10.22M
XOMA annual revenue is $10.22 million

Revenue Analysts estimate

$31.90M
XOMA annual revenue is currently -67.96% lower than the consensus analysts' forecast

Revenue 1-year change

+114.8%
XOMA annual revenue is up +114.8% year-on-year

Revenue Sector rank

28.78%
XOMA annual revenue is higher than 28.78% of companies in Healthcare sector

EPS

EPS

-$1.65
XOMA annual earnings per share is -$1.65

EPS Analysts estimate

-$0.56
XOMA annual earnings per share is currently +196.39% higher than the consensus analysts' forecast

EPS 1-year change

+59.16%
XOMA annual earnings per share is up +59.16% year-on-year

EPS Sector rank

42.53%
XOMA annual earnings per share is higher than 42.53% of companies in Healthcare sector

Profit

Gross profit

-
XOMA annual gross profit value is unknown

Gross margin

-
XOMA annual gross profit margin value is unknown

Operating profit

-$9.07M
XOMA annual operating income is -$9.07 million

Operating margin

-88.77%
XOMA annual operating profit margin is -88.77%

Net income

-$13.82M
XOMA annual net profit is -$13.82 million

Net margin

-135.23%
XOMA annual net profit margin is -135.23%

Expenses

Total expenses

$19.29M
XOMA annual total expenses is $19.29 million

Operating expenses

$19.29M
XOMA annual total operating expenses is $19.29 million

Cost of goods sold

-
XOMA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$34.48M
XOMA annual SGA is $34.48 million

Depreciation and amortization

$216.00K
XOMA annual depreciation & amortization is $216.00 thousand

Interest expense

$13.84M
XOMA annual interest expense is $13.84 million

Income tax

-$5.66M
XOMA annual income tax is -$5.66 million

EBIT & EBITDA

EBIT

-$5.64M
XOMA annual earnings before interest & taxes is -$5.64 million

EBITDA

-$5.42M
XOMA annual EBITDA is -$5.42 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$221.28M
XOMA annual total assets is $221.28 million

Non current assets

$95.67M
XOMA annual long term assets is $95.67 million

Current assets

$125.60M
XOMA annual total current assets is $125.60 million

Cash and cash equivalents

$101.65M
XOMA annual cash & cash equivalents is $101.65 million

Accounts receivable

$1.84M
XOMA annual accounts receivable is $1.84 million

Inventory

-
XOMA annual inventory value is unknown

Liabilities

Total liabilities

$139.36M
XOMA annual total liabilities is $139.36 million

Long term liabilities

$114.98M
XOMA annual total long term liabilities is $114.98 million

Current liabilities

$24.37M
XOMA annual total current liabilities is $24.37 million

Accounts payable

$1.05M
XOMA annual accounts payable is $1.05 million

Debt

Total debt

$119.20M
XOMA annual total debt is $119.20 million

Total debt 1-year change

-4.22%
XOMA annual total debt is down -4.22% year-on-year

Long term debt

$107.36M
XOMA annual long term debt is $107.36 million

Short term debt

$11.84M
XOMA annual short term debt is $11.84 million

Equity & Capital

Shareholders equity

$81.92M
XOMA annual stockholders equity is $81.92 million

Book value

$81.87M
XOMA annual book value is $81.87 million

Retained earnings

-$1.24B
XOMA annual retained earnings is -$1.24 billion

Working capital

$101.23M
XOMA annual working capital is $101.23 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$13.75M
XOMA annual cash flow from operations is -$13.75 million

Cash from operations 1-year change

+24.29%
XOMA annual cash flow from operations is up +24.29% year-on-year

Cash from investing

-$28.26M
XOMA annual cash flow from investing activities is -$28.26 million

Cash from investing 1-year change

-3874.54%
XOMA annual cash flow from investing activities is down -3874.54% year-on-year

Cash from financing

-$11.13M
XOMA annual cash flow from financing activities is -$11.13 million

Cash from financing 1-year change

-109.23%
XOMA annual cash flow from financing activities is down -109.23% year-on-year

CAPEX

CAPEX

$20.00K
XOMA annual capital expenditures is $20.00 thousand

CAPEX 1-year change

+17.65%
XOMA annual capital expenditures is up +17.65% year-on-year

Free Cash Flow

Free cash flow

-$13.77M
XOMA annual free cash flow is -$13.77 million

Free cash flow 1-year change

+24.25%
XOMA annual free cash flow is up +24.25% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
XOMA annual gross profit margin value is unknown

Operating margin

-88.77%
XOMA annual operating profit margin is -88.77%

Net margin

-135.23%
XOMA annual net profit margin is -135.23%

ROA & ROE

ROA

-6.07%
XOMA annual return on assets is -6.07%

ROE

-16.20%
XOMA annual return on equity is -16.20%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
XOMA price to earnings ratio value is unknown

PE ratio Sector rank

-
XOMA price to earnings ratio is unknown

PB Ratio

PB ratio

2.98
XOMA price to book ratio is 2.98

PB ratio Sector rank

72.7%
XOMA price to book ratio is higher than 72.7% of companies in Healthcare sector

PS Ratio

PS ratio

23.86
XOMA price to sales ratio is 23.86

PS ratio Sector rank

87.56%
XOMA price to sales ratio is higher than 87.56% of companies in Healthcare sector

Enterprise value

Enterprise value

$261.43M
XOMA enterprise value is $261.43 million

Enterprise value Sector rank

62%
XOMA enterprise value is higher than 62% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-48.21
XOMA EV/EBITDA is -48.21

EV/EBITDA Sector rank

2.78%
XOMA EV/EBITDA is higher than 2.78% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.15
XOMA annual current ratio is 5.15

Quick ratio

-
XOMA annual quick ratio value is unknown

Leverage

Debt to equity

1.44
XOMA annual debt to equity ratio is 1.44

Interest coverage ratio

-0.41
XOMA annual interest coverage ratio is -0.41

Risk & Stability

Piotroski F-Score

-
XOMA piotroski f-score value is unknown

Altman Z-Score

-6.27
XOMA altman z-score is -6.27

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Mar 19, 25 HC Wainwright & Co.
Buy
Feb 3, 25 HC Wainwright & Co.
Buy
Jan 7, 25 HC Wainwright & Co.
Buy
Dec 13, 24 HC Wainwright & Co.
Buy
Dec 3, 24 HC Wainwright & Co.
Buy
Dec 2, 24 HC Wainwright & Co.
Buy
Oct 23, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Aug 15, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

VNDA logo
Vanda Pharmaceuticals (VNDA)
OLMA logo
Olema Pharmaceuticals (OLMA)
VSTM logo
Verastem (VSTM)
AQST logo
Aquestive Therapeutics (AQST)
TSHA logo
Taysha Gene Therapies (TSHA)
ATAI logo
Atai Life Sciences NV (ATAI)
EBS logo
Emergent BioSolutions (EBS)
CERS logo
Cerus (CERS)
AVIR logo
Atea Pharmaceuticals (AVIR)
  • What is the ticker symbol for XOMA?
  • Does XOMA pay dividends?
  • What sector is XOMA in?
  • What industry is XOMA in?
  • What country is XOMA based in?
  • When did XOMA go public?
  • Is XOMA in the S&P 500?
  • Is XOMA in the NASDAQ 100?
  • Is XOMA in the Dow Jones?
  • When was XOMA's last earnings report?
  • When does XOMA report earnings?
  • Should I buy XOMA stock now?

What is the ticker symbol for XOMA?

The ticker symbol for XOMA is NASDAQ:XOMA

Does XOMA pay dividends?

Yes, XOMA pays dividends. The last payment was $0.54, with an ex-dividend date on January 3, 2025

What sector is XOMA in?

XOMA is in the Healthcare sector

What industry is XOMA in?

XOMA is in the Biotechnology industry

What country is XOMA based in?

XOMA is headquartered in United States

When did XOMA go public?

XOMA's initial public offering (IPO) was on June 6, 1986

Is XOMA in the S&P 500?

No, XOMA is not included in the S&P 500 index

Is XOMA in the NASDAQ 100?

No, XOMA is not included in the NASDAQ 100 index

Is XOMA in the Dow Jones?

No, XOMA is not included in the Dow Jones index

When was XOMA's last earnings report?

XOMA's most recent earnings report was on Mar 17, 2025

When does XOMA report earnings?

The next expected earnings date for XOMA is May 9, 2025

Should I buy XOMA stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page